Citation Impact
Citing Papers
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
The Role of Innate and Adaptive Immunity in Parkinson's Disease
2013
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators
2006 Standout
Toxin-induced models of Parkinson’s disease
2005
Bilateral Fetal Mesencephalic Grafting in Two Patients with Parkinsonism Induced by 1-Methyl-4-Phenyl-L,2,3,6-Tetrahydropyridine (MPTP)
1992
Lack of major olfactory dysfunction in MPTP‐induced parkinsonism
1992
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Evolution of motor fluctuations in Parkinson's disease: A longitudinal study over 6 years
1999
Normal frontal perfusion in patients with frozen gait
1998
Reactive Oxygen Species and the Central Nervous System
1992 Standout
Molecular mechanisms of L-DOPA-induced dyskinesia
2008
Developmental neurotoxicity of industrial chemicals
2006 Standout
Parkinson disease
2017 Standout
Mitochondrial Dysfunction in Neurodegeneration
1997
Parkinson's disease
2021 Standout
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
1995 Standout
TRPC1-mediated Inhibition of 1-Methyl-4-phenylpyridinium Ion Neurotoxicity in Human SH-SY5Y Neuroblastoma Cells
2004
Paraquat exposure as an etiological factor of Parkinson's disease
2006
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
1998 StandoutNature
Hydrogen peroxide mediates amyloid β protein toxicity
1994 Standout
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Parkinsonian Symptomatology An Anatomical and Physiological Analysisaa
1988
Parkinson's disease: clinical features and diagnosis
2008 Standout
The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease
1988
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
2006
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
2003 StandoutNobel
Movement disorder emergencies
2004
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
2007 Standout
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
1999
Parkinson's disease
2009 Standout
Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
2001 Standout
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
1991 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions
1994
Axonal and transneuronal transport in the transmission of neurological disease: Potential role in system degenerations, including alzheimer's disease
1987
Mitochondrial control of cell death
2000 Standout
Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena
2004 Standout
Mitochondrial dysfunction in Parkinson's disease
2007
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
2000 Standout
Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions
1988
Primate models of movement disorders of basal ganglia origin
1990 Standout
Mitochondrial free radical generation, oxidative stress, and aging
2000 Standout
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
P450 enzymes and Parkinson's disease: The story so far
1998
Role of mitochondria in the etiology and pathogenesis of Parkinson's disease
1995
Mice Lacking α-Synuclein have an Attenuated Loss of Striatal Dopamine Following Prolonged Chronic MPTP Administration
2004
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
1992
Parkinson's Disease
1998 Standout
De novo administration of ropinirole and bromocriptine induces less dyskinesia than L ‐dopa in the MPTP‐treated marmoset
1998
Oxygen free radical producing activity of polymorphonuclear leukocytes in patients with Parkinson's disease
1992
Non-motor features of Parkinson disease
2017 Standout
The role of the basal ganglia in habit formation
2006 Standout
Complex I Is the Major Site of Mitochondrial Superoxide Production by Paraquat
2007 Standout
(E)-4-Hydroxy-2-Nonenal May be Involved in the Pathogenesis of Parkinson’s Disease
1998
Sympathetic Innervation in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Primate Model of Parkinson’s Disease
2003
The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease
1990
Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long term losses of dopamine neurons in offspring a potential new model of parkinson s disease
2003
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Effects of medial and lateral caudate-putamen lesions on place- and cue-guided behaviors in the water maze: relation to thigmotaxis
1999
The Brain's Default Network
2008 Standout
The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
2014
Morris water maze: procedures for assessing spatial and related forms of learning and memory
2006 Standout
Parkinson's Disease
2003 Standout
Dopamine, learning and motivation
2004 Standout
Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function
1995 Standout
The MPTP-treated primate as a model of motor complications in PD
2003
Freezing of gait in PD
2001
Levodopa-Induced Neurotoxicity
1997
Oxidative damage and mitochondrial decay in aging.
1994 Standout
The functional anatomy of basal ganglia disorders
1989 Standout
The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism
1994
Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease
1985 Nature
Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)—induced parkinsonism in the macaque monkey
1985
The Free Radical Theory of Aging Matures
1998 Standout
Neurotoxins, parkinsonism and Parkinson's disease
1987
Diagnosis and Treatment of Parkinson Disease
2020 Standout
ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT?
1986
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
2000 Standout
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
1997 StandoutScience
Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine
2000 Standout
Primate models of dyskinesia: The experimental approach to the study of basal ganglia-related involuntary movement disorders
1987
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
1990 StandoutScience
Cell Death During Development of the Nervous System
1991 Standout
Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
1986
Long oligonucleotide microarrays for African green monkey gene expression profile analysis
2007 StandoutNobel
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
The development of mitochondrial medicine.
1994
Cellular localization of tyrosine hydroxylase mRNA and cholecystokinin mRNA-containing cells in the ventral mesencephalon of the common marmoset: effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
1992
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Long‐term follow‐up of early dopa treatment in Parkinson's disease
1986
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
1985
Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus
1985
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Works of P. Ballard being referenced
Parkinsonism Induced By 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP): Implications for Treatment and the Pathogenesis of Parkinson’s Disease
1984
Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)
1985